Prot # M14-868: A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 or Genotype 3 I

Project: Research project

Project Details

Effective start/end date11/11/1411/11/17


  • Covance Inc. (Prot # M14-868)
  • AbbVie Inc. (Prot # M14-868)